{"id":1884,"date":"2024-03-28T11:09:14","date_gmt":"2024-03-28T11:09:14","guid":{"rendered":"https:\/\/stoxpo.com\/?p=1884"},"modified":"2024-03-28T11:09:16","modified_gmt":"2024-03-28T11:09:16","slug":"avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/","title":{"rendered":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Avalo Therapeutics secures AVTX-009 and $185 million in funding, poised for breakthroughs in inflammatory disease treatments<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">The acquisition of AVTX-009 represents a key milestone for Avalo as it aims to address the significant unmet needs in severe autoimmune diseases like HS. Dr. Garry A. Neil, CEO and Chairman of Avalo, expressed confidence in the potential of AVTX-009 to emerge as a best-in-class treatment option. The company&#8217;s focus on inflammatory conditions aligns well with its strategic vision, backed by recent data validating the inhibition of IL-1\u03b2 in diseases like HS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Patrick J. Crutcher, former CEO of AlmataBio, highlighted the promise of AVTX-009 and expressed optimism about its advancement into Phase 2 trials under Avalo&#8217;s stewardship. The acquisition underscores Avalo&#8217;s commitment to identifying and accelerating the development of clinically meaningful therapies.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With the private placement financing, Avalo expects to extend its cash runway into 2027, providing ample resources to support operations and the development of AVTX-009. The financing deal, led by prominent investors, reflects confidence in Avalo&#8217;s strategic direction and the potential of its pipeline candidates.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avalo&#8217;s leadership team remains unchanged, ensuring continuity in driving the company&#8217;s growth trajectory. With the completion of the acquisition and financing transactions, Avalo is well-positioned to advance AVTX-009 through clinical trials and further strengthen its position in the field of inflammatory disease therapeutics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/finance.yahoo.com\/news\/avalo-acquires-anti-il-1-200100092.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Viking Therapeutics\u2019 Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Avalo Therapeutics secures AVTX-009 and $185 million in funding, poised for breakthroughs in inflammatory disease treatments The acquisition of AVTX-009 represents a key milestone for Avalo as it aims to address the significant unmet needs in severe autoimmune diseases like HS. Dr. Garry A. Neil, CEO and Chairman of Avalo, expressed confidence in the potential [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1424,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,360],"tags":[],"coauthors":[453],"class_list":["post-1884","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-mid-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Avalo Therapeutics secures AVTX-009 and $185 million in funding, poised for breakthroughs in inflammatory disease treatments The acquisition of AVTX-009 represents a key milestone for Avalo as it aims to address the significant unmet needs in severe autoimmune diseases like HS. Dr. Garry A. Neil, CEO and Chairman of Avalo, expressed confidence in the potential [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-28T11:09:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-28T11:09:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal\",\"datePublished\":\"2024-03-28T11:09:14+00:00\",\"dateModified\":\"2024-03-28T11:09:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/\"},\"wordCount\":251,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088530-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Mid-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/\",\"name\":\"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088530-scaled.jpg\",\"datePublished\":\"2024-03-28T11:09:14+00:00\",\"dateModified\":\"2024-03-28T11:09:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088530-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088530-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"radiology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/28\\\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/","og_locale":"en_US","og_type":"article","og_title":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo","og_description":"Avalo Therapeutics secures AVTX-009 and $185 million in funding, poised for breakthroughs in inflammatory disease treatments The acquisition of AVTX-009 represents a key milestone for Avalo as it aims to address the significant unmet needs in severe autoimmune diseases like HS. Dr. Garry A. Neil, CEO and Chairman of Avalo, expressed confidence in the potential [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/","og_site_name":"Stoxpo","article_published_time":"2024-03-28T11:09:14+00:00","article_modified_time":"2024-03-28T11:09:16+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal","datePublished":"2024-03-28T11:09:14+00:00","dateModified":"2024-03-28T11:09:16+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/"},"wordCount":251,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg","articleSection":["Biotechnology","Mid-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/","name":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg","datePublished":"2024-03-28T11:09:14+00:00","dateModified":"2024-03-28T11:09:16+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088530-scaled.jpg","width":2560,"height":1707,"caption":"radiology"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/28\/avalo-expands-pipeline-with-acquisition-of-almatabio-and-financing-deal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=1884"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1884\/revisions"}],"predecessor-version":[{"id":1885,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1884\/revisions\/1885"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1424"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=1884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=1884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=1884"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=1884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}